Category: CovidienSyndicate content

Michigan judge shoots down settlement alleged by Biomet in poaching spat with Stryker | Medtech legal news for the week of July 28, 2014

July 28, 2014 by MassDevice

Here's a look at some of the top legal news stories for medical device companies this week: Judge nixes alleged settlement in Stryker, Biomet poaching spat; Boston Scientific loses bids to exclude testimony in pelvic mesh trials; Occlutech claims another win over St. Jude Medical; Align Tech declares a 'total win' as federal circuit reverses ITC ruling; Report: Medtronic shareholder sues to block Covidien merger

Judge nixes alleged settlement in Stryker, Biomet poaching spat

July 23, 2014 by Brad Perriello

Haemonetics taps outgoing Covidien CFO Dockendorff for board | Personnel Moves

July 28, 2014 by Brad Perriello

Charles Dockendorff, the outgoing CFO at Covidien, is named to the board of directors at Haemonetics.

Haemonetics taps outgoing Covidien CFO Dockendorff for board | Personnel Moves

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Covidien's Q3 sales meet The Street, earnings top estimates

July 25, 2014 by Brad Perriello

Covidien's fiscal 3rd-quarter sales come in dead even with expectations on Wall Street as its earnings top analysts' consensus estimate.

Covidien's Q3 sales meet The Street, earnings top estimates

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Report: Medtronic shareholder sues to block Covidien merger

July 24, 2014 by Brad Perriello

A Medtronic shareholder is reportedly looking to block the pending, $43 billion merger with Covidien, arguing that the deal leaves stockowners on the hook for significant tax liabilities.

Report: Medtronic shareholder sues to block Covidien merger

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Abbott CEO chides critics of corporate inversions | Medtech Wall Street news for the week of July 21, 2014

July 24, 2014 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: Abbott CEO defends inversions amid corporate exodus furor; Medtronic fights tax dodging rhetoric in Covidien merger; Allergan cuts 1,500 jobs, faces SEC complaint; A countdown to failure for Valeant's hostile $53B Allergan takeover; GE Healthcare idles for another quarter

Abbott CEO defends inversions amid corporate exodus furor

July 18, 2014 by Arezu Sarvestani

Abbott CEO defends inversions amid corporate exodus furor

JNJ looks to bolster "subscale" cardiovascular business | The week in medtech M&A

July 23, 2014 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week: Johnson & Johnson eyes acquisitions in cardiovascular, elsewhere; Abbott CEO defends inversions amid corporate exodus furor; Medtronic fights tax dodging rhetoric in Covidien merger; Could Medtronic-Covidien deal get caught in anti-inversion legislation?; Siemens sells clinical microbiology biz to Beckman Coulter

Johnson & Johnson eyes acquisitions in cardiovascular, elsewhere

July 16, 2014 by Brad Perriello

YYmeta

Covidien promotes Hanson to group president role | Personnel Moves

July 22, 2014 by Brad Perriello

Covidien names Bryan Hanson group president, with oversight of all of the medical device company's businesses.

Covidien promotes Hanson to group president role | Personnel Moves

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp